XBiotech's cancer drug meets survival threshold in phase II trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: XBIT) | Delayed: 1.93 -0.04 (2.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.97 | 52 Week High | $25.00 | |||
| Open | $1.95 | 52 Week Low | $6.36 | |||
| Day High | $1.95 | P/E | N/A | |||
| Day Low | $1.86 | EPS | $0.00 | |||
| Volume | 121,737 | |||||
